ACADIA Pharmaceuticals (ACAD) Stock Price & Financial Analysis
ACADIA Pharmaceuticals Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About ACADIA Pharmaceuticals
What is the current stock price for ACAD?
As of the latest trading session, ACAD stock trades at $22.20. The 52-week range is $13.40–$28.35, with a day range of $21.71–$22.48.
What is the P/E ratio for ACAD?
ACADIA Pharmaceuticals's trailing P/E ratio is 9.8, meaning investors pay $9.8 for every $1 of annual earnings. The forward P/E is 5.7, reflecting analyst expectations for future earnings. ACADIA Pharmaceuticals operates in the Healthcare sector.
Does ACAD pay dividends?
ACADIA Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ACAD?
Based on 17 analysts, the consensus for ACAD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ACAD?
ACADIA Pharmaceuticals's market capitalization is $3.80B, classifying it as a mid-cap company. ACADIA Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.